Eckert & Ziegler

Update in progress

EUZ.F (Frankfurt)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Eckert & Ziegler SE develops and sells isotope technology components for medical, scientific and industrial use worldwide, with Medical and Isotope Products segments. It offers iodine-125 prostate implants, ruthenium-106/iodine-125 eye applicators for choroidal melanoma, brachytherapy seeds, radiopharmaceuticals, radiochemistry and lab equipment, X-ray and therapeutic sources, GA-68 generators, hot cells, Tc-99m generators and calibration sources. Formerly Eckert & Ziegler Strahlen- und Medizintechnik AG, renamed in March 2024. Founded 1992, Berlin.

Company score

Sentiment: 0.31; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.24; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.17; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.11; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive